Biohaven Pharmaceutical Holding Price to Free Cash Flow Ratio 2016-2021 | BHVN

Historical price to free cash flow ratio values for Biohaven Pharmaceutical Holding (BHVN) since 2016. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Biohaven Pharmaceutical Holding Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2021-12-03 103.56 0.00
2021-09-30 138.91 $-13.54 0.00
2021-06-30 97.08 $-13.10 0.00
2021-03-31 68.35 $-12.65 0.00
2020-12-31 85.71 $-12.04 0.00
2020-09-30 65.01 $-10.78 0.00
2020-06-30 73.11 $-8.87 0.00
2020-03-31 34.03 $-9.50 0.00
2019-12-31 54.44 $-7.86 0.00
2019-09-30 41.72 $-6.34 0.00
2019-06-30 43.79 $-6.75 0.00
2019-03-31 51.47 $-3.99 0.00
2018-12-31 36.98 $-5.14 0.00
2018-09-30 37.55 $-6.06 0.00
2018-06-30 39.52 $-5.16 0.00
2018-03-31 25.76 $-5.65 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.783B $0.064B
Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. It focuses on the identification and development of orphan neurologic indications and other neurological pathways. The company's pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity that modulates glutamate and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate receptor antagonism which are in clinical trial stage. Biohaven Pharmaceutical Holding Company Ltd. is based in NEW HAVEN, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $125.010B 7.90
Bio-Rad Laboratories (BIO.B) United States $22.443B 45.55
QIAGEN (QGEN) Netherlands $12.357B 20.93
Arcus Biosciences (RCUS) United States $3.105B 0.00
Emergent Biosolutions (EBS) United States $2.254B 8.10
ADC Therapeutics SA (ADCT) Switzerland $1.478B 0.00
Myovant Sciences (MYOV) United Kingdom $1.368B 0.00
Zymeworks (ZYME) Canada $0.861B 0.00
Ambrx Biopharma (AMAM) United States $0.337B 0.00
SQZ Biotechnologies (SQZ) United States $0.319B 0.00
Enzo Biochem (ENZ) United States $0.162B 15.90